Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes

Volume: 63, Issue: 9, Pages: 1847 - 1856
Published: Jun 20, 2020
Abstract
Aims/hypothesis Lipid abnormalities are associated with diabetic kidney disease and CHD, although their exact role has not yet been fully explained. Sphingomyelin, the predominant sphingolipid in humans, is crucial for intact glomerular and endothelial function. Therefore, the objective of our study was to investigate whether sphingomyelin impacts kidney disease and CHD progression in individuals with type 1 diabetes. Methods Individuals ( n =...
Paper Details
Title
Sphingomyelin and progression of renal and coronary heart disease in individuals with type 1 diabetes
Published Date
Jun 20, 2020
Volume
63
Issue
9
Pages
1847 - 1856
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.